Biopharma in China: Innovation, Trends and Dealmaking - Hardcover
by Sven Agten, Ben Wu
$44.99
Quantity
01
Pay over time for orders over $35.00 with
Language:EnglishPublisher:Palgrave MacMillanISBN-13:9789819714704ISBN-10:9819714702UPC:9789819714704Book Category:Business & Economics, MedicalBook Subcategory:Economics, Research, InternationalBook Topic:ComparativeSize:8.27 x 5.83 x 0.44 inchesWeight:0.7716Product ID:SCZFC21VK9
Biopharma in China: Innovation, Trends and Dealmaking
This book provides an insider's overview of the emerging Chinese biopharma sector, its dynamics and trends, first bust and boom cycle, long-term perspectives, and how as a foreign company or investor to tap into this. China has gone from a country with no innovation in drug discovery, to a country which starts to out-license its biopharma technology to the rest of the world. The Chinese biopharma...
Language:EnglishPublisher:Palgrave MacMillanISBN-13:9789819714704ISBN-10:9819714702UPC:9789819714704Book Category:Business & Economics, MedicalBook Subcategory:Economics, Research, InternationalBook Topic:ComparativeSize:8.27 x 5.83 x 0.44 inchesWeight:0.7716Product ID:SCZFC21VK9
Ben Wu has close to 30 years of experience in the pharmaceutical industry, holding senior executive positions in the Asia Pacific region for multinationals like J&J and Sanofi. He was active in several China originated biopharma companies, and is the founding CEO of Citrine Medicine, a venture capital backed biopharma.
Originally from Belgium, Sven Agten has been living and working in China...
Originally from Belgium, Sven Agten has been living and working in China...
Publisher: Palgrave MacMillan
Edition
2024 Edition
Contributor(s)
Author
Free shipping on orders over $75. Standard shipping takes 3-7 business days. Returns accepted within 30 days of purchase.